HighTower Advisors’s CAS Medical Systems, Inc. CASM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-225,889
Closed -$549K 2584
2019
Q1
$549K Sell
225,889
-15,000
-6% -$32.3K ﹤0.01% 1413
2018
Q4
$385K Sell
240,889
-19,046
-7% -$35.5K ﹤0.01% 1484
2018
Q3
$592K Buy
259,935
+19,046
+8% +$40.6K ﹤0.01% 1381
2018
Q2
$470K Hold
240,889
﹤0.01% 1480
2018
Q1
$304K Sell
240,889
-4,600
-2% -$5.19K ﹤0.01% 1665
2017
Q4
$191K Hold
245,489
﹤0.01% 1938
2017
Q3
$227K Hold
245,489
﹤0.01% 1830
2017
Q2
$284K Hold
245,489
﹤0.01% 1655
2017
Q1
$354K Buy
245,489
+74,212
+43% +$113K ﹤0.01% 1475
2016
Q4
$275K Hold
171,277
﹤0.01% 1521
2016
Q3
$298K Hold
171,277
﹤0.01% 1456
2016
Q2
$318K Hold
171,277
﹤0.01% 1302
2016
Q1
$241K Buy
171,277
+151,677
+774% +$247K ﹤0.01% 1723
2015
Q4
$37K Buy
+19,600
New +$27.7K ﹤0.01% 1911

HighTower Advisors's CASM Position: Q2 2019 in Review

HighTower Advisors sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 225,889 shares — an estimated $549K sold.

HighTower Advisors first reported a position in CASM in Q4 2015 and held it in 14 quarters. The position peaked at $592K in Q3 2018. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.

  • HighTower Advisors reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
  • HighTower Advisors sold 225,889 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $549K.
  • HighTower Advisors first reported a position in CAS Medical Systems, Inc. in Q4 2015 and held it in 14 quarters.
  • HighTower Advisors's CAS Medical Systems, Inc. position peaked at $592K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.

Based on HighTower Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.